BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29398083)

  • 1. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
    Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.
    Lorés-Motta L; van Beek AE; Willems E; Zandstra J; van Mierlo G; Einhaus A; Mary JL; Stucki C; Bakker B; Hoyng CB; Fauser S; Clark SJ; de Jonge MI; Nogoceke E; Koertvely E; Jongerius I; Kuijpers TW; den Hollander AI
    Am J Hum Genet; 2021 Aug; 108(8):1367-1384. PubMed ID: 34260947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
    Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
    de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
    Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
    van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
    Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
    García M; Álvarez L; Nogacka AM; González-Iglesias H; Escribano J; Fernández-Vega B; Fernández-Vega Á; Fernández-Vega L; Coca-Prados M
    Acta Ophthalmol; 2015 Dec; 93(8):e658-66. PubMed ID: 26152901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic complement activation in age-related macular degeneration.
    Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
    PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.
    Zhang H; Morrison MA; Dewan A; Adams S; Andreoli M; Huynh N; Regan M; Brown A; Miller JW; Kim IK; Hoh J; Deangelis MM
    BMC Med Genet; 2008 Jun; 9():51. PubMed ID: 18541031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.
    Wu L; Tao Q; Chen W; Wang Z; Song Y; Sheng S; Li P; Zhou J
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):170-4. PubMed ID: 23233260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.
    Khandhadia S; Hakobyan S; Heng LZ; Gibson J; Adams DH; Alexander GJ; Gibson JM; Martin KR; Menon G; Nash K; Sivaprasad S; Ennis S; Cree AJ; Morgan BP; Lotery AJ
    Ophthalmology; 2013 Aug; 120(8):1612-8. PubMed ID: 23562165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
    Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Activation Levels Are Related to Disease Stage in AMD.
    Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
    Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
    PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration.
    Geerlings MJ; Kremlitzka M; Bakker B; Nilsson SC; Saksens NT; Lechanteur YT; Pauper M; Corominas J; Fauser S; Hoyng CB; Blom AM; de Jong EK; den Hollander AI
    JAMA Ophthalmol; 2017 Jan; 135(1):39-46. PubMed ID: 27918759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
    van de Ven JP; Smailhodzic D; Boon CJ; Fauser S; Groenewoud JM; Chong NV; Hoyng CB; Klevering BJ; den Hollander AI
    Mol Vis; 2012; 18():2271-8. PubMed ID: 22933840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population.
    Momozawa Y; Akiyama M; Kamatani Y; Arakawa S; Yasuda M; Yoshida S; Oshima Y; Mori R; Tanaka K; Mori K; Inoue S; Terasaki H; Yasuma T; Honda S; Miki A; Inoue M; Fujisawa K; Takahashi K; Yasukawa T; Yanagi Y; Kadonosono K; Sonoda KH; Ishibashi T; Takahashi A; Kubo M
    Hum Mol Genet; 2016 Nov; 25(22):5027-5034. PubMed ID: 28173125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.